China bears the world’s heaviest burden of chronic disease in absolute terms. Its 2017-2025 national plan emphasized prevention and early detection, with an organizational component for care coordination, while digital technologies stem largely from separate Chinese policies on the internet and health. What the plan has concretely produced remains difficult to measure: independent evaluations of policy texts and design have been published, but they do not necessarily constitute a complete independent assessment of the implementation and results of the 2017-2025 plan.
The essentials
- China launched a national plan in 2017 aimed at reducing the incidence of chronic disease through prevention, early detection, and strengthened care capacity; digital technologies, including electronic health records and telemedicine, are partially embedded in it but also stem from other national policies.
- The plan sets numerical targets for screening and management of certain chronic diseases, without an explicit numerical target for digital adoption. Frontiers in Public Health (2026) indicates that its own method does not directly measure the real effects of implementation.
- The Chinese system combines multi-level hospitals, primary care facilities, and public health institutions; counties, townships, villages, and communities play distinct roles, an architecture designed to decentralize monitoring without losing coordination.
- Inequalities between provinces and weak capacity in rural areas widen the gap between national guidelines and their local implementation.
- The Chinese model will pose a sequencing question to middle-income countries: consolidate human primary care first, or bet on technology to accelerate chronic disease prevention.
One country, 400 million chronic patients
The numbers are massive. More than 400 million Chinese live with at least one chronic disease—hypertension, diabetes, cardiovascular disease, cancer, chronic obstructive pulmonary disease. The four cardiovascular and cerebrovascular diseases, cancers, chronic respiratory diseases, and diabetes make up the group targeted by the premature mortality objective. The World Bank reported a share of 68.6% of total disease burden attributed to non-communicable diseases, based on 2009 data.
Over three decades, China reduced infant mortality and infectious disease at a pace praised by the World Health Organization. This success produced an aging population, more exposed to lifestyle-related diseases, which strains a care system designed for acute rather than chronic conditions.
The traditional Chinese model was built to treat acute episodes in large urban hospitals. A hypertensive patient who returns every three months, a diabetic who must be monitored daily: this type of continuous care overwhelmed system capacity. Waiting lists grew in tertiary hospitals in major cities, while community health centers remained underused, sometimes due to lack of patient trust, sometimes due to lack of trained doctors.
The 2017-2025 plan: three levers, one architecture
Facing this reality, the central government launched the national chronic disease reduction plan in 2017. Its designers chose three main levers.
Early detection is an important axis of the plan, following measures for prevention and control of risk factors. The plan sets targets for screening and management of hypertensive and diabetic patients, with implementation of targeted and opportunistic screening in primary facilities, as well as regular examinations for certain age groups. The idea is economically sound: treating a heart attack costs infinitely more than a daily blood pressure pill properly prescribed ten years earlier.
Digital technology is one of the plan’s axes, notably through internet innovation applied to health. The plan encourages the use of digital technologies, including the internet of things, to measure and transmit health data, coupled with information systems, without an explicit program for deploying connected monitoring devices for all patients. Telemedicine should allow a doctor at a provincial referral hospital to remotely supervise the monitoring of a rural patient cared for at a village health center.
The plan includes an organizational and coordination component. The plan strengthens the three-tier chain that structures the Chinese health system: tertiary referral hospitals at the top, district hospitals in the middle, community and rural health centers at the base. The goal is for stable chronic patients to be monitored at the level closest to their home, with complex cases moving up to higher levels. This “tiered care” architecture, known as fenshen jiuyi in official documents, is at the center of the model.
Digital health: what has actually been deployed
China has real assets in digital health. It has more than one billion smartphone users, mature mobile payment infrastructure, and heavyweight technology players—Alibaba Health, Ping An Good Doctor, WeDoctor—that have invested heavily in teleconsultation platforms. Between 2018 and 2023, China’s digital health market grew at a pace few countries can match.
This momentum has been partially connected to the government plan. Electronic health record systems have been deployed in many provinces. Telemedicine platforms have been integrated into the care pathway in certain regions. The Covid-19 epidemic accelerated this movement: remote consultations, which struggled to find their place before 2020, became common practice in major cities between 2020 and 2022.
For chronic diseases, the most promising application is home monitoring. A hypertensive patient equipped with a connected blood pressure cuff can transmit daily measurements to their primary care doctor without traveling. If the algorithm detects a drift, an alert is raised. In theory, this model reduces preventable hospitalizations and improves medication adherence. In practice, its deployment occurs at varying rates across regions.
Adoption of digital health tools varies by region, affecting urban and rural areas differently.
The Frontiers in Public Health article published in 2026 analyzing this plan notes that its evaluation focuses on policy content rather than actual effects. Published data come from varied sources, with measurement approaches that may differ across provincial contexts.
The blind spot: the distance between Beijing and the provinces
China is a continent-sized state. A national directive applicable in Guangdong must be adapted to Gansu, a rural province whose per-capita income is three times lower and whose medical capacity bears no comparison. Gaps between provinces constitute a major difficulty in plan implementation.
China’s primary care system has long suffered from problems of trust and competence. Chinese prefer large urban hospitals, perceived as more reliable, to local community centers. This preference is not irrational: primary care facilities have personnel and capacity deficits compared to hospitals, deficits notably concerning training, equipment, and doctor compensation. The 2017-2025 plan seeks to reverse this hierarchy of trust, but the structural dynamics that produce it—compensation, training, job attractiveness—evolve slowly.
The World Bank identifies several structural difficulties in the Chinese system, notably misaligned incentives between system levels and coordination deficits.
The incentive problem is particularly acute. Community health centers are funded partly on a fee-for-service basis. The fee-for-service payment structure influences the clinical priorities of primary care doctors. As long as this payment structure is not corrected, the plan asks primary care doctors to do more with less, which, in all health systems, produces disappointing results. On the tension between human resources and digital health ambition, China’s difficulties echo the recruitment and retention challenges for healthcare workers that simultaneously constrain European health systems.
Lessons from comparable countries
China is not the only country to have launched a major national plan against chronic disease. Thailand, examined in a WHO evaluation of its health systems, offers an instructive comparison. Bangkok developed solid primary care from the 1990s onward, achieving universal coverage in 2002. The result on chronic disease: better hypertension and diabetes control rates than countries with higher per-capita GDP. The Thai lesson is that the length and consistency of investment in primary care matter more than technological sophistication.
India, analyzed in several World Bank assessments between 2020 and 2025, illustrates the opposite risk. Ambitious digital health programs have been launched—the Ayushman Bharat platform, universal digital health identification—but their impact on chronic disease remains limited due to lack of sufficiently strong primary care to make them work. Digital technology amplifies what exists; it does not replace it.
China has the financial and technological means necessary to deploy sophisticated tools, but strengthening primary care capacity and digital deployment evolve at different rates across regions and sectors. The 2017-2025 plan thus raises a sequencing question: strengthen human primary care first before adding digital technology, or use digital technology to accelerate that strengthening.
The answer the Chinese plan provides—deploying both simultaneously—is defensible, but it demands considerable implementation and coordination capacity. And technology adoption dynamics show that even in simpler institutional contexts, diffusion of digital technologies occurs first in organizations that already have the human resources to absorb them.
The limits of what 2025 allows us to conclude
The plan’s deadline was 2025. Its results remain, at this stage, difficult to evaluate according to standardized independent evaluation criteria.
Figures published by Chinese authorities—rising screening rates, expanding electronic record coverage, multiplying teleconsultations—are real but their interpretation would benefit from standardized measurement methods. A screening rate of 60% in one province and 30% in another tells us little about health impact if we don’t know whether screened patients are actually treated and followed.
Frontiers in Public Health, in its 2026 analysis, points out a methodological gap: textual evaluation lacks external validation by real-world effects data, making it difficult to attribute observed health changes. China has given itself a clear direction and documented tools. What it has not yet clearly established is whether implementation matched ambition.
This gap between intention and evidence is a common problem for major national health plans and does not disqualify the Chinese plan more than any other. The designers of the next cycle, which should cover 2026-2030, will need to define an evaluation architecture that establishes what actually worked.
The answer to this question will determine whether China exports a model or only an ambition. And by 2030, middle-income countries facing the same epidemiological pressures will watch carefully what Beijing is able to demonstrate.
Sources
- Frontiers in Public Health (2026), Analysis of China’s National Chronic Disease Reduction Plan 2017-2025: https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2026.1729450/full
- World Bank, China Health Systems Review 2025 (no verified link available)
- WHO, Thailand Health Systems Review (no verified link available)
- World Bank, India Health Assessments 2020-2025 (no verified link available)
- Chinese government health policy documents 2017-2025 (no verified link available)
